Qiming Medical-B held the first extraordinary general meeting of shareholders in 2024 on October 10, as well as the H-share category shareholders' meeting and the non-listed foreign shareholder meeting, all of which were successfully completed in Hangzhou, China. Except for the 2nd and 6th resolutions that were not passed, all other resolutions were formally approved by the shareholders. Ms. Li Xiaojuan was elected as a director, and the company's articles of association, shareholder meeting rules, board of directors meeting rules, and supervisory board meeting rules were revised. In addition, the board of directors obtained a general authorization to repurchase H-share shares. The meeting was chaired by Mr. Hu Dingxu, the chairman, and all voting results complied with the relevant...Show More

Qiming Medical-B held the first extraordinary general meeting of shareholders in 2024 on October 10, as well as the H-share category shareholders' meeting and the non-listed foreign shareholder meeting, all of which were successfully completed in Hangzhou, China. Except for the 2nd and 6th resolutions that were not passed, all other resolutions were formally approved by the shareholders. Ms. Li Xiaojuan was elected as a director, and the company's articles of association, shareholder meeting rules, board of directors meeting rules, and supervisory board meeting rules were revised. In addition, the board of directors obtained a general authorization to repurchase H-share shares. The meeting was chaired by Mr. Hu Dingxu, the chairman, and all voting results complied with the relevant laws and regulations of China and the company's articles of association, being legitimate and effective. Executive directors Mr. Lin Haosheng, Mr. Ma Liqiao, and Ms. Liu Meirong, non-executive directors Mr. Zhang Ao and Mr. Wang Wei, as well as independent non-executive directors Mr. Hu Dingxu and Mr. Sun Zhiwei, all attended the meeting.